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A Homozygous Mutation in the Tight-Junction Protein
JAM3 Causes Hemorrhagic Destruction of the Brain,
Subependymal Calcification, and Congenital Cataracts
Ganeshwaran H. Mochida,1,2,3 Vijay S. Ganesh,1 Jillian M. Felie,1 Danielle Gleason,1 R. Sean Hill,1,2
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The tight junction, or zonula occludens, is a specialized cell-cell junction that regulates epithelial and endothelial permeability, and it is
an essential component of the blood-brain barrier in the cerebrovascular endothelium. In addition to functioning as a diffusion barrier,
tight junctions are also involved in signal transduction. In this study, we identified a homozygousmutation in the tight-junction protein
gene JAM3 in a large consanguineous family from the United Arab Emirates. Somemembers of this family had a rare autosomal-recessive
syndrome characterized by severe hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts. Their
clinical presentation overlaps with some reported cases of pseudo-TORCH syndrome as well as with cases involving mutations in occlu-
din, another component of the tight-junction complex. However, massive intracranial hemorrhage distinguishes these patients from
others. Homozygosity mapping identified the disease locus in this family on chromosome 11q25 with a maximum multipoint LOD
score of 6.15. Sequence analysis of genes in the candidate interval uncovered a mutation in the canonical splice-donor site of intron
5 of JAM3. RT-PCR analysis of a patient lymphoblast cell line confirmed abnormal splicing, leading to a frameshift mutation with early
termination. JAM3 is known to be present in vascular endothelium, although its roles in cerebral vasculature have not been implicated.
Our results suggest that JAM3 is essential for maintaining the integrity of the cerebrovascular endothelium as well as for normal lens
development in humans.Tight junctions are composed of a complex of transmem-
brane proteins, which include claudins, occludins and
JAMs (junctional adhesion molecules), and cytoplasmic
plaque proteins, which include various scaffolding,
adaptor and regulatory proteins.1 The molecular composi-
tion of the tight junction varies among different tissue
types.2 In the cerebrovascular endothelium, tight junc-
tions are an essential component of the blood-brain
barrier.
There are several human genetic disorders resulting from
mutations in genes that encode tight-junction proteins.
These include familial hypercholanemia (MIM 607748),3
autosomal-recessive deafness 29 (DFNB29; MIM 605608),4
and 49 (DFNB49; MIM 610153),5 and Nance-Horan
syndrome (MIM 302350).6 The wide range of clinical
presentation of these disorders underscores the variable
functions and molecular composition of tight junctions
in different organs. However, no disorder of tight junctions
associated with severe hemorrhage has been reported to
date, despite the fact that tight junctions are essential to
the integrity of vascular endothelial cells in various organs.
Here we report a mutation in the tight-junction gene JAM3
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brain as a cardinal feature.
In the United Arab Emirates, we ascertained a large
consanguineous pedigree with its origin in Baluchistan
(the region involving southeastern Iran, western Pakistan,
and southwestern Afghanistan). In this pedigree, eight
individuals in four branches showed a unique clinical
syndrome characterized by hemorrhagic destruction of
the brain parenchyma, subependymal calcification, and
congenital cataracts (family OTH10700; Figure 1). All
surviving patients developed generalized spasticity, exag-
gerated deep-tendon reflexes, and seizures. Hepatomegaly
was documented in three patients, and of the four patients
who had abdominal ultrasound, three were found to have
renal anomalies. Thrombocytopenia was seen in one
patient in the setting of bacterialmeningitis, andnopatient
had persistently abnormal neutrophil counts (clinical find-
ings are summarized in Table 1). Screening for congenital
infections (serological examination for cytomegalovirus,
toxoplasmosis, and rubella, plus urine examination for
cytomegalovirus particles) was negative in individuals
VIII-17, VIII-21, andVIII-22.Of note, there is a second auto-
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Figure 1. Pedigree Drawing of the Family OTH10700
Filled symbols denote affected individuals. The left half of the symbol is filled for the syndrome of hemorrhagic destruction of the brain,
subependymal calcification, and congenital cataracts, and the right half of the symbol is filled for short rib-polydactyly syndrome, type
III. Genotyped individuals are indicated with an asterisk.type III (MIM 263510), that segregates independently in
this family, and one individual (VIII-21) was affected by
bothconditions.Clinical descriptionofpart of this pedigree
was previously published.7 All affected individualswhohad
brain imaging showed evidence of a destructive brain
disorder (Figure 2). Individuals VIII-21, VIII-22, and VIII-
10 had multifocal intraparenchymal hemorrhage with
associated liquefaction, predominantly in the cerebral
white matter and basal ganglia (Figures 2A–2D). A series of
T1-weighted sagittal brain MR images of individual VIII-
10 obtained at the age of 4 weeks are presented as a supple-
mental movie (Movie S1). Individual VIII-27 had massive
cystic destruction of the cerebral white matter and basal
ganglia, resulting in large ventricles (Figure 2E). Individual
VIII-29 had a porencephalic cyst centered in the left frontal
subcortical white matter, enlarged lateral ventricles, and
reduced white matter volume, indicative of destructive
changes (Figure 2F). Subependymal, basal-ganglia, and
white-matter calcification was evident in all patients who
underwent a brain CT scan (VIII-21, VIII-22, and VIII-29;
Figures 2B, 2C, and 2F, respectively; in addition, a brain
CT image of individual VIII-17 was published in Al-Gazali
et al.7 [this individual is referred to as case 3 in the paper]).
Abnormalities of the posterior fossa were seen in some
cases: individual VIII-21 had a thin midbrain and pons;
individual VIII-10 hadmildly atrophic pons, cerebellar ver-
mis, and hemispheres; individual VIII-27 had small pons,
medulla, and cerebellar hemispheres, a small, upwardly
rotated vermis, and a large fourth ventricle; and individual
VIII-29 had a small right cerebellar hemisphere. It could not
be determined whether these posterior fossa findings were
the result of primary injury or were secondary to supraten-
torial lesions. No definitive evidence of a developmental
cortical malformation was noted in any of the patients,The Americanalthough the severe destructive lesions made it impossible
to rule out a coexisting developmental malformation. The
distribution of both hemorrhage and cystic changes is
most suggestive of a disorder involving small vessels. The
exact time of onset of the intracranial lesions is difficult to
determine. However, the imaging characteristics suggested
lesions of varying ages. The signal characteristics of hemor-
rhagic lesions on MRI of individuals VIII-21 (MRI was per-
formed postmortem because the patient died immediately
after birth) and VIII-10 (initial MRI was performed at
4 days of age) were suggestive of acute or subacute lesions.
Individual VIII-27 was noted to have enlarged ventricles
on a third-trimester ultrasound and large areas of hemi-
spheric porencephaly on postnatal MRI, suggesting very
remote hemorrhage or infarction.
We collected peripheral blood samples from the affected
children and parents after obtaining written informed
consent according to the protocols approved by the
participating institutions. All the research procedures
were in accordance with the ethical standards of the
responsible national and institutional committees on
human-subject research. A total of 13 individuals (indi-
cated with an asterisk in Figure 1) were genotyped via Illu-
mina HumanHap550-Duo SNPmicroarray. Only one block
of homozygosity on chromosome 11q25 emerged as being
shared by all affected individuals tested (VIII-21, VIII-22,
VIII-10, and VIII-29). The list of homozygous blocks is
presented in Table S1. The candidate interval was defined
by the recombinant SNP markers rs1627835 and
rs1893054 and was 8.5 cM (3.2 Mb) in size. One of the
unaffected siblings, VIII-26, shared homozygosity in the
proximal portion of this interval, and this region was elim-
inated from the candidate interval. Thus, the minimal crit-
ical interval was defined by SNP markers rs12271299 andJournal of Human Genetics 87, 882–889, December 10, 2010 883
Table 1. Summary of Clinical Findings of the Family OTH10700
Individual Gender Age
Birth Head
Circumference
Current Head
Circumference Seizures
Ophthalmological
Findings
Cardiac
Findings Hepatomegaly
Renal
Findings Thrombocytopenia
Other Organ
Involvement
VIII-17 Male Died at
9 days
35 cm
(0.4 SD)
Not
applicable
No
information
Bilateral
congenital
cataracts
Patent ductus
arteriosus and
ventricular
septal defect
Yes Normal
by renal
ultrasound
No No
information
VIII-21 Female Died a few
minutes
after birth
34 cm
(0.5 SD)
Not
applicable
No
information
Bilateral
congenital
catarcts
No
information
Yes Bilateral cystic
dysplasia
No
information
Short rib
polydactyly,
type III
VIII-22 Male 3 years
4 months
33 cm
(1.2 SD)
45.5 cm
(2.7 SD)
Yes Bilateral congenital
cataracts and
microphthalmia
No
information
No
information
No
information
No Small phallus,
undescended
testes
VIII-10 Female 1 year
2 months
No
information
38.8 cm
(5.4 SD)
Yes Bilateral congenital
cataracts
Systolic heart
murmur, normal
cardiac ultrasound
Yes No
information
Yes
(during bacterial
meningitis)
No
information
VIII-27 Male Died at
2 months
No
information
Not
applicable
No
information
Bilateral congenital
cataracts, slightly
pale optic discs,
normal retina
Normal cardiac
ultrasound
No
information
Small ectopic
right kidney
in the iliac fossa
No
information
No
information
VIII-29 Female 6 years
1 month
No
information
41 cm
(8.1 SD)
Yes Bilateral congenital
cataracts
No
heart murmur
No
information
Ectopic, malrotated
left kidney in the
iliac fossa
No No
information
Individual ID numbers correspond to those in Figure 1.
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Figure 2. Brain Imaging of the Family
OTH10700
A T1-weighted axial brain MRI (A) and
brain CT (B) of individual VIII-21, a brain
CT of individual VIII-22 (C), and a
T1-weighted sagittal brain MRI of indi-
vidualVIII-10 (D) showmultifocal intrapar-
enchymal hemorrhage, predominantly in
the cerebral white matter and basal ganglia
(arrows). A T2-weighted axial brain MRI of
individual VIII-27 (E) shows massive cystic
destruction of the cerebral white matter
and basal ganglia and resulting large lateral
ventricles. A brain CT of individual VIII-29
(F) shows a porencephalic cyst centered in
the left frontal subcortical white matter
(asterisk), enlarged lateral ventricles, and
reduced white-matter volume, indicative
of destructive changes. Subependymal
calcification is evident on CT (B, C and F,
arrowheads). Figure 2A is from the same
MRI series previously published in Al-
Gazali et al.7 (this individual is referred to
as case 4 in the paper).rs1893054 and measured 1.9 cM (1.1 Mb) (Figure 3A).
Because of computational limitations, LOD scores across
this region were calculated with a set of 175 SNP markers
(every eighth marker out of the 1400 markers encom-
passed the minimal critical interval) with SimWalk2.8
The calculation was made under the assumption of a reces-
sive mode of inheritance with 100% penetrance and
a disease allele prevalence of 0.0001, and a maximummul-
tipoint LOD score of 6.15 was obtained (Figure 3B).
A second calculation involving a different set of 175 SNP
markers in the same interval gave comparable results,
with a slightly narrower peak and a maximum multipoint
LOD score of 5.88 (data not shown). Sequence analysis of
the coding exons of the nine protein-coding RefSeq genes
in the linked interval (Figure 3C; see also Table S2) revealed
a candidate mutation in JAM3 (Junctional Adhesion Mole-
cule 3; MIM 606871; NM_032801.3) only. The homozy-
gous nucleotide change occurred at the first base position
of intron 5 (c.747þ1G>T; Figure 4A). All affected children
were homozygous for this change and the parents, who are
obligate carriers, were all heterozygous. Two different
web-based programs, Neural Network9 and NetGene2,10
predict that the c.747þ1G>T nucleotide change abolishes
the wild-type splice donor site and reveal a cryptic splice
donor site 19 base pairs downstream into intron 5
(Figure 4A). Sequences of the primers for coding exons of
JAM3 were designed with Primer311 and are presented in
Table S3. We sequenced the intron 5 splice donor site of
JAM3 in a total of 370 control individuals (740 chromo-
somes), including 270 controls of European descent (Cor-
iell Institute for Medical Research) and 100 United Arab
Emirates nationals, and did not find the same nucleotide
change, either in a homozygous or a heterozygous state.
RT-PCR experiments with transformed lymphoblast cell
lines from one of the patients and her parent confirmed
that this mutation disrupted normal splicing of JAM3.The AmericanRNA was extracted from the cell lines, and cDNA was
generated by reverse-transcriptase reaction, amplified by
PCR, and sequenced (primer sequences are presented in
Table S4). As predicted by the splice prediction programs,
the patient’s sample showed only the product in which
the first 19 bases of intron 5 were inserted between exons
5 and 6 (Figure 4B). This insertion results in a frameshift,
and 25 aberrant amino acids are incorporated before
early termination (p.Val250LeufsX26; Figure 4C). The re-
sulting protein is predicted to lack the transmembrane
domain and PDZ-binding motif and therefore is expected
to be nonfunctional. The parent’s sample showed only
wild-type sequence, and the abnormal splice product
seen in the patient was not detected (Figure 4B). This
might suggest that the abnormal splice product is less
stable, and the normal splice product is preferentially
amplified when both products are present.
The family we studied shows some similarities to cases of
pseudo-TORCH syndrome (MIM251290) reported in
the literature but has distinct clinical features as well.
Pseudo-TORCH syndrome is characterized by congenital
microcephaly, intracranial calcification, seizures, severe
developmental delay, and sometimes thrombocytopenia
and hepatomegaly.12 Another form of pseudo-TORCH sy-
ndrome has emerged and is characterized by band-like
intracranial calcification, simplified cerebral gyral pattern,
polymicrogyria, and progressive microcephaly but lacks
hepatomegaly or thrombocytopenia.13–15 Recently, the
latter group of patients was found to have mutations in
another tight-junction gene, OCLN (occludin; MIM
602876), underscoring the importance of tight-junction
proteins in the developing brain.16 However, the patients
we studied did not show evidence of polymicrogyria or
other developmental malformations of the cerebral cortex,
and the patients with OCLNmutations did not have intra-
cranial hemorrhage or congenital cataracts. No otherJournal of Human Genetics 87, 882–889, December 10, 2010 885
Figure 3. Homozygosity Mapping and Linkage Analysis of the Family OTH10700
(A) SNP genotyping results on chromosome 11q25. A block of homozygosity shared only by the affected individuals tested (VIII-21,
VIII-22, VIII-10, and VIII-29) is evident and delineated by the vertical lines. Red and blue indicate homozygous SNP markers, and green
indicates heterozygous SNP markers.
(B) LOD score graph of the candidate region. A maximum multipoint LOD score of 6.15 was obtained within the candidate interval.
(C) Genes within the candidate region, shown as the RefSeq track of the UCSC Genome Browser (NCBI build 36/hg18).reported patients show exactly the same clinical features as
the family we report here, and we have not encountered
a similar condition in our own experience with more than
1000 cases of congenital brain disorders. Perhaps the most
similar patients in the literature are two brothers reported
by Knoblauch et al.; these brothers had intracranial hemor-
rhage and calcification but no cataracts.17 GenomicDNAof
these siblings was sequenced for the coding exons of JAM3,
but no mutation was identified (data not shown).
JAMs are immunoglobulin superfamily proteins that
localize to tight junctions of epithelial and endothelial886 The American Journal of Human Genetics 87, 882–889, Decembcells.18 They are implicated in a wide range of physiolog-
ical and pathological functions through cell adhesion
involving homophilic and heterophilic interactions. These
activities include barrier function, leukocyte migration,
platelet activation, and angiogenesis (reviewed by Mandell
and Parkos19). Full-length human JAM3 is an approxi-
mately 43 kDa protein with two extracellular immuno-
globulin-like domains, a transmembrane domain, and
a C-terminal PDZ-binding motif.20 Human JAM3 is ex-
pressed at a high level in the brain, kidney, and placenta.20
It is interesting to note that three out of four affecteder 10, 2010
Figure 4. Mutation in JAM3
(A) Genomic DNA analysis of JAM3. Affected individual VIII-29
shows a G-to-T change in the canonical splice donor site of
JAM3 intron 5 (c.747þ1G>T; asterisk). Her mother (VII-5) is
heterozygous for the mutation. A cryptic splice donor site 19 bp
downstream is at least equally as potent as the wild-type donor
site (confidence score 0.46 [wild-type] versus 0.67 [cryptic] by Net-
Gene2). CTRL ¼ normal control.
(B) mRNA analysis of JAM3. On the mRNA level, the mutation
results in the usage of the downstream cryptic splice donor site
and causes a 19 bp insertion in the affected individual (VIII-29).
Only normal splice products are seen in her mother (VII-5).
(C) Predicted protein product of themutant allele. The 19 bp inser-
tion is expected to result in a truncating protein product with 25
aberrant amino acid residues in the C terminus (WT ¼ wild-type
protein, MUT ¼mutant protein). The truncation occurs proximal
to the transmembrane domain (TM) and PDZ-binding motif (þ).individuals who had abdominal imaging (VIII-21, VIII-27,
and VIII-29) were found to have abnormalities in one or
both kidneys (Table 1).
Engineeredmicedeficient for themouseorthologof JAM3
(Jam3; also known as JAM-C) have been reported21 and
show growth retardation and increased susceptibility to
multilobar pneumonia and related death.22 They have
nuclear cataracts23 and defects in multiple organ system
functions, including spermatid differentiation,21 peripheral
nerveconduction,24 andgranulocytehomeostasis.22Abnor-
malities in the central nervous system have not been re-
ported in these mice, however. Jam3 (referred to as JAM-2
in Aurrand-Lions et al.25) is reported to be absent in vascula-
ture of the adult mouse brain,25 and in situ hybridization of
developing andadultmousebrains showsonly a low level of
Jam3 expression (Allen Mouse Brain Atlas and Allen Devel-
oping Mouse Brain Atlas). This is in sharp contrast to the
high level of expressionof JAM3 in thehumanadult brain,20
suggesting that the tissue distribution of orthologous tight-
junctionproteins varies significantlybetween species. In the
peripheral nervous system, Jam3 is localized to SchwannThe Americancells at junctions between adjoining myelin end loops,
and JAM3 has a similar localization pattern in human sural
nerves.24 The presence of exaggerated deep-tendon reflexes
in the patients we studied suggests that severe defects in
nerve conduction are rather unlikely, but mild conduction
defects cannot be ruled out without electrophysiological
studies.
Cataracts are seen in Jam3-deficient mice as well as the
patients presented here. Of note, NHS, the gene mutated
in Nance-Horan syndrome, which is characterized by
congenital cataracts, dental anomalies, and intellectual
disability, has been shown to localize to tight junctions
and be expressed in the developing lens epithelium.26
Thus, tight-junction proteins seem to play an important
role in normal lens development. In addition, Jam3 and
JAM3 are found in the mouse23 and human retina,27
respectively. However, Jam3-deficient mice have normal
retinal morphology,23 and we did not find evidence of
retinal pathology in the one patient who had undergone
a documented fundoscopic examination (VIII-27). The
role of JAM3 in retinal development is yet to be elucidated,
but it has been shown to regulate transmigration of granu-
locytes in human retinal pigment epithelium, and it might
play a role in retinal inflammatory processes.27
Three of the patients we studied had various renal abnor-
malities, and one had congenital heart disease (Table 1).
Jam3-deficient mice have no apparent abnormalities in
the heart or kidneys, however.28 A patient with hypo-
plastic left-heart and congenital thrombocytopenia was
reported to have a paracentric inversion in 11q with
a breakpoint in or near JAM3.28 Studies of additional
patients with mutations in JAM3 would help determine
its potential role in human cardiac and renal development.
Although JAM3 is present on the surface of platelets,29 we
believe the most likely cause of the intracerebral hemor-
rhage in these patients was malfunctioning tight junctions
of cerebrovascular endothelial cells. The absence of
a systemic bleeding diathesis in any of the patients argues
against abnormalities of platelets or coagulation. In addi-
tion, three of the patients were confirmed to have a normal
platelet count. Thrombocytopenia was noted in another
patient, but in the setting of severe meningitis. However,
there is also evidence that disruption of JAM3 function
leads to a decrease, rather than an increase, in permeability
of human dermal microvascular endothelial cells30 and
human umbilical-vein endothelial cells.31 Therefore, the
effect of the JAM3 mutation we identified might not
simply be increased vascular permeability throughout the
body, and it might argue for a unique function of JAM3
in the cerebrovascular endothelium. Intraparenchymal
hemorrhage without definable cause is sometimes seen
in term neonates,32 and it would also be of interest to
investigate the role of JAM3 in such cases without other
organ involvement.
Interestingly, mutations in COL4A1 (collagen, type IV,
alpha 1; MIM 120130), which encodes a vascular basement
membrane protein, lead to clinical presentations thatJournal of Human Genetics 87, 882–889, December 10, 2010 887
overlap with those of the patients we studied and include
antenatal intracranial hemorrhage,33 porencephaly (MIM
175780),34 brain small-vessel disease with hemorrhage or
vascular leukoencephalopathy (MIM 607595),35,36 and
hereditary angiopathy with nephropathy, aneurysms,
and muscle cramps (MIM 611773).37 Ocular abnormalities
including congenital cataracts have also been reported.36
Even though COL4A1 is expressed in blood vessels of
numerous organs,38 the brain is the most susceptible organ
for hemorrhage in the presence of COL4A1 mutations.
This might further support a small-vessel origin of intracra-
nial pathology of the patients presented here.Supplemental Data
Supplemental Data include one movie and four tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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